Royal Bank of Canada’s AnaptysBio ANAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$29K Sell
1,296
-52
-4% -$1.16K ﹤0.01% 5754
2025
Q1
$26K Buy
1,348
+126
+10% +$2.43K ﹤0.01% 5439
2024
Q4
$17K Sell
1,222
-2,870
-70% -$39.9K ﹤0.01% 5672
2024
Q3
$136K Buy
4,092
+2,024
+98% +$67.3K ﹤0.01% 4683
2024
Q2
$51K Buy
2,068
+1,129
+120% +$27.8K ﹤0.01% 5261
2024
Q1
$20K Sell
939
-6,241
-87% -$133K ﹤0.01% 5467
2023
Q4
$154K Buy
7,180
+4,537
+172% +$97.3K ﹤0.01% 4782
2023
Q3
$48K Buy
2,643
+1,154
+78% +$21K ﹤0.01% 5310
2023
Q2
$31K Buy
1,489
+347
+30% +$7.22K ﹤0.01% 5532
2023
Q1
$25K Sell
1,142
-1,148
-50% -$25.1K ﹤0.01% 5550
2022
Q4
$71K Buy
2,290
+1,359
+146% +$42.1K ﹤0.01% 5221
2022
Q3
$23K Buy
931
+130
+16% +$3.21K ﹤0.01% 5590
2022
Q2
$16K Sell
801
-27,054
-97% -$540K ﹤0.01% 5725
2022
Q1
$689K Sell
27,855
-12,211
-30% -$302K ﹤0.01% 3559
2021
Q4
$1.39M Buy
40,066
+2,342
+6% +$81.4K ﹤0.01% 3043
2021
Q3
$1.02M Sell
37,724
-53
-0.1% -$1.44K ﹤0.01% 3228
2021
Q2
$979K Buy
37,777
+36,843
+3,945% +$955K ﹤0.01% 3274
2021
Q1
$20K Buy
+934
New +$20K ﹤0.01% 5914
2020
Q4
Sell
-3
Closed 6485
2020
Q3
$0 Sell
3
-43
-93% ﹤0.01% 6078
2020
Q2
$1K Sell
46
-100
-68% -$2.17K ﹤0.01% 5894
2020
Q1
$2K Sell
146
-1,782
-92% -$24.4K ﹤0.01% 5765
2019
Q4
$32K Sell
1,928
-1,045
-35% -$17.3K ﹤0.01% 5059
2019
Q3
$104K Buy
2,973
+465
+19% +$16.3K ﹤0.01% 4208
2019
Q2
$141K Buy
2,508
+199
+9% +$11.2K ﹤0.01% 4105
2019
Q1
$169K Buy
2,309
+551
+31% +$40.3K ﹤0.01% 3896
2018
Q4
$112K Sell
1,758
-2,022
-53% -$129K ﹤0.01% 4043
2018
Q3
$377K Sell
3,780
-63,126
-94% -$6.3M ﹤0.01% 3515
2018
Q2
$4.75M Buy
66,906
+27,029
+68% +$1.92M ﹤0.01% 1705
2018
Q1
$4.15M Buy
39,877
+37,112
+1,342% +$3.86M ﹤0.01% 1786
2017
Q4
$279K Buy
2,765
+1,126
+69% +$114K ﹤0.01% 3529
2017
Q3
$57K Buy
1,639
+1,583
+2,827% +$55.1K ﹤0.01% 4601
2017
Q2
$1K Sell
56
-244
-81% -$4.36K ﹤0.01% 5603
2017
Q1
$8K Buy
+300
New +$8K ﹤0.01% 5366